VectivBio
Dan Donahue, MPH, MBA, currently serves as Senior Director and Head of U.S. Development Operations at Ironwood Pharmaceuticals, specializing in clinical trial management and program oversight. With extensive experience across various organizations, Dan has held significant roles, including Director of Clinical Operations at Passage Bio, where management of rare disease clinical trials was paramount. Previous positions include consultant roles and leadership within clinical operations at Carisma Therapeutics, the University of Pennsylvania, PPD, and AstraZeneca. Dan's career has been marked by a strong focus on project management, regulatory compliance, and ensuring quality assurance in clinical research, supported by advanced degrees in public health and business administration.
This person is not in any offices
VectivBio
VectivBio AG is a global biotechnology company committed to making a difference in the lives of patients suffering from serious rare diseases.